Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reducing VEGF-B Signaling Ameliorates Renal Lipotoxicity and Protects against Diabetic Kidney Disease
Annelie Falkevall, Annika Mehlem, Isolde Palombo, et al.
Cell Metabolism (2017) Vol. 25, Iss. 3, pp. 713-726
Open Access | Times Cited: 152

Showing 1-25 of 152 citing articles:

Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors
Ralph A. DeFronzo, William Reeves, Alaa S. Awad
Nature Reviews Nephrology (2021) Vol. 17, Iss. 5, pp. 319-334
Closed Access | Times Cited: 392
Emerging Targets in Type 2 Diabetes and Diabetic Complications
Sevgican Demir, Peter P. Nawroth, Stephan Herzig, et al.
Advanced Science (2021) Vol. 8, Iss. 18
Open Access | Times Cited: 322
Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities
Lucas Opazo-Ríos, Sebastián Mas, Gema Marín‐Royo, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 7, pp. 2632-2632
Open Access | Times Cited: 248
Signaling pathways of chronic kidney diseases, implications for therapeutics
Qian Yuan, Ben Tang, Chun Zhang
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 220
Impact of different ectopic fat depots on cardiovascular and metabolic diseases
Daniele Ferrara, Fabrizio Montecucco, Franco Dallegri, et al.
Journal of Cellular Physiology (2019) Vol. 234, Iss. 12, pp. 21630-21641
Closed Access | Times Cited: 160
Diabetes mellitus: Classification, mediators, and complications; A gate to identify potential targets for the development of new effective treatments
Samar A. Antar, Nada A. Ashour, Marwa Sharaky, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115734-115734
Open Access | Times Cited: 150
Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease
Alla Mitrofanova, Sandra Merscher, Alessia Fornoni
Nature Reviews Nephrology (2023) Vol. 19, Iss. 10, pp. 629-645
Closed Access | Times Cited: 111
The Mechanism of Hyperglycemia-Induced Renal Cell Injury in Diabetic Nephropathy Disease: An Update
Tong Wu, Lei Ding, Vivian Andoh, et al.
Life (2023) Vol. 13, Iss. 2, pp. 539-539
Open Access | Times Cited: 84
Crosstalk among podocytes, glomerular endothelial cells and mesangial cells in diabetic kidney disease: an updated review
Shiwan Hu, Hang Xing, Yu Wei, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 25
Acute Kidney Injury and Progression of Diabetic Kidney Disease
Samuel Mon-Wei Yu, Joseph V. Bonventre
Advances in Chronic Kidney Disease (2018) Vol. 25, Iss. 2, pp. 166-180
Open Access | Times Cited: 158
Lipotoxicity in Kidney, Heart, and Skeletal Muscle Dysfunction
Hiroshi Nishi, T Higashihara, Reiko Inagi
Nutrients (2019) Vol. 11, Iss. 7, pp. 1664-1664
Open Access | Times Cited: 140
Elevation of JAML Promotes Diabetic Kidney Disease by Modulating Podocyte Lipid Metabolism
Yi Fu, Yu Sun, Mei Wang, et al.
Cell Metabolism (2020) Vol. 32, Iss. 6, pp. 1052-1062.e8
Open Access | Times Cited: 136
Phosphorylation of Acetyl-CoA Carboxylase by AMPK Reduces Renal Fibrosis and Is Essential for the Anti-Fibrotic Effect of Metformin
Mardiana Lee, Marina Katerelos, Kurt Gleich, et al.
Journal of the American Society of Nephrology (2018) Vol. 29, Iss. 9, pp. 2326-2336
Open Access | Times Cited: 119
Renal Lipid Metabolism and Lipotoxicity in Diabetes
Laongdao Thongnak, Anchalee Pongchaidecha, Anusorn Lungkaphin
The American Journal of the Medical Sciences (2019) Vol. 359, Iss. 2, pp. 84-99
Closed Access | Times Cited: 103
Pyroptosis: A New Frontier in Kidney Diseases
Kejia Zhang, Qi Wu, Shimin Jiang, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 60
New insights into renal lipid dysmetabolism in diabetic kidney disease
Alla Mitrofanova, George W. Burke, Sandra Merscher, et al.
World Journal of Diabetes (2021) Vol. 12, Iss. 5, pp. 524-540
Open Access | Times Cited: 58
Dapagliflozin Ameliorates Renal Tubular Ferroptosis in Diabetes via SLC40A1 Stabilization
Bin Huang, Wenjie Wen, Shandong Ye
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-17
Open Access | Times Cited: 41
Podocyte injury of diabetic nephropathy: Novel mechanism discovery and therapeutic prospects
Xiandeng Li, Ying Zhang, Xiaodong Xing, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115670-115670
Open Access | Times Cited: 41
Inhibition of VEGF-B signaling prevents non-alcoholic fatty liver disease development by targeting lipolysis in the white adipose tissue
Annelie Falkevall, Annika Mehlem, Erika Folestad, et al.
Journal of Hepatology (2023) Vol. 78, Iss. 5, pp. 901-913
Open Access | Times Cited: 32
The role of lipotoxicity in kidney disease: From molecular mechanisms to therapeutic prospects
Linan Ren, Haiying Cui, Yao Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114465-114465
Open Access | Times Cited: 26
Glucocorticoid activation of anti-inflammatory macrophages protects against insulin resistance
Giorgio Caratti, Ulrich Stifel, Bozhena Caratti, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 23
NDUFS4 regulates cristae remodeling in diabetic kidney disease
Koki Mise, Jianyin Long, Daniel L. Galvan, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Lipid metabolism disorder in diabetic kidney disease
Yi-Zhen Han, Bo-Xuan Du, Xingyu Zhu, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 11
Autophagy activation contributes to lipid accumulation in tubular epithelial cells during kidney fibrosis
Qi Yan, Yuan Song, Lu Zhang, et al.
Cell Death Discovery (2018) Vol. 4, Iss. 1
Open Access | Times Cited: 67
Diabetic Kidney Disease, Endothelial Damage, and Podocyte-Endothelial Crosstalk
Cindy Lora Gil, Erika Hooker, Bruno Larrivée
Kidney Medicine (2020) Vol. 3, Iss. 1, pp. 105-115
Open Access | Times Cited: 62
Page 1 - Next Page

Scroll to top